Methods for the use of 5′-adenosine diphosphate ribose (ADPR)

A method for treating, managing, or preventing an RNA virus-related disease or condition in a patient, said method comprising administering to the patient an effective amount of 5′-adenosine diphosphate ribose (ADPR), or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, stereoisomer, isotopologue, or polymorph thereof;

• wherein the patient has or is at risk of developing an RNA virus-related disease or condition;
• and
• wherein the RNA virus-related disease or condition is caused by an RNA virus, wherein the RNA virus is human respiratory syncytial virus (HRSV).